Evidence map›Paper›PMID 33271569›Full record

ReviewMedical principles and practice : international journal of the Kuwait University, Health Science Centre2021

Metabolomics: The Stethoscope for the Twenty-First Century.

Hutan Ashrafian, Viknesh Sounderajah, Robert Glen, Timothy Ebbels, Benjamin J Blaise, Dipak Kalra, Kim Kultima, Ola Spjuth, Leonardo Tenori, Reza M Salek and 9 more

Abstract readReview
In one paragraph

Review in Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Multi-Omic Approach to Newborn Screening: Opportunities and Challenges.International journal of neonatal screening · 2024
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Hutan AshrafianInstitute of Global Health Innovation and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Viknesh SounderajahInstitute of Global Health Innovation and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Robert GlenInstitute of Global Health Innovation and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Timothy EbbelsInstitute of Global Health Innovation and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Benjamin J BlaiseInstitute of Global Health Innovation and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Dipak KalraDepartment of Medical Informatics and Statistics, University of Ghent, Ghent, Belgium.
Kim KultimaDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Ola SpjuthDepartment of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Leonardo TenoriDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Reza M SalekEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Namrata KaleEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Kenneth HaugEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Daniel SchoberDepartment of Stress and Developmental Biology, Leibniz Institute of Plant Biochemistry, Halle (Saale), Germany.
Philippe Rocca-SerraDepartment of Engineering Science, Oxford e-Research Centre, University of Oxford, Oxford, United Kingdom.
Claire O'DonovanEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Christoph SteinbeckInstitute for Inorganic and Analytical Chemistry, Friedrich-Schiller-University, Jena, Germany.
Isaac CanoHospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Pedro de AtauriDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona and CIBERHD (CIBER de Enfermedades hepáticas y digestivas), Barcelona, Spain.
Marta CascanteDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona and CIBERHD (CIBER de Enfermedades hepáticas y digestivas), Barcelona, Spain.

Funding

Biotechnology and Biological Sciences Research Council BB/E025080/1Biotechnology and Biological Sciences Research Council BB/I000771/1Medical Research Council MR/S019669/1
6 · The paper itself

Abstract

Metabolomics encompasses the systematic identification and quantification of all metabolic products in the human body. This field could provide clinicians with novel sets of diagnostic biomarkers for disease states in addition to quantifying treatment response to medications at an individualized level. This literature review aims to highlight the technology underpinning metabolic profiling, identify potential applications of metabolomics in clinical practice, and discuss the translational challenges that the field faces. We searched PubMed, MEDLINE, and EMBASE for primary and secondary research articles regarding clinical applications of metabolomics. Metabolic profiling can be performed using mass spectrometry and nuclear magnetic resonance-based techniques using a variety of biological samples. This is carried out in vivo or in vitro following careful sample collection, preparation, and analysis. The potential clinical applications constitute disruptive innovations in their respective specialities, particularly oncology and metabolic medicine. Outstanding issues currently preventing widespread clinical use are scalability of data interpretation, standardization of sample handling practice, and e-infrastructure. Routine utilization of metabolomics at a patient and population level will constitute an integral part of future healthcare provision.

Indexed as

MetabolomicsPrecision MedicineStethoscopesHumansMetabolomicsPersonalised medicinePrecision medicine

Identifiers

PMID33271569
PMCPMC8436726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.